TPST icon

Tempest Therapeutics
TPST

Overview Fund Activity

28 hedge funds and large institutions have $3.94M invested in Tempest Therapeutics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
3
Closed
4
Calls
$117K
Puts
$163K
Net Calls
-$46K
Net Calls Change
-$21K

Top Buyers

1
ACM
1
Altium Capital Management
New York
$763K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$308K
3
FW
3
FullCircle Wealth
Texas
$68.2K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$63.4K
5
Morgan Stanley
5
Morgan Stanley
New York
$140K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
VF
2
Virtu Financial
New York
$0
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$0
4
TAM
4
Tocqueville Asset Management
New York
$45.9K
5
GCP
5
GSA Capital Partners
United Kingdom
$133K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$8.45K +$8.43K +463 +46,300%
PA
27
Parallel Advisors
California
$330 – – –
CIBC Private Wealth Group
28
CIBC Private Wealth Group
Georgia
$186 – – –
Citadel Advisors
29
Citadel Advisors
Florida
– -$202K -7,095 Closed
VF
30
Virtu Financial
New York
– -$136K -4,771 Closed
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
– -$54.9K -1,930 Closed
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
– -$59 -2 Closed
1
2